Skip to main content
NCBI home page
Gut logoLink to Gut
. 1991 Nov;32(11):1261–1263. doi: 10.1136/gut.32.11.1261

Neurochemistry of hepatic encephalopathy.

C O Record 1
PMCID: PMC1379148  PMID: 1752451

Full text

PDF
1261

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al Mardini H., Bartlett K., Record C. O. Blood and brain concentrations of mercaptans in hepatic and methanethiol induced coma. Gut. 1984 Mar;25(3):284–290. doi: 10.1136/gut.25.3.284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Al Mardini H., Leonard J., Bartlett K., Lloyd S., Record C. O. Effect of methionine loading and endogenous hypermethioninaemia on blood mercaptans in man. Clin Chim Acta. 1988 Aug 15;176(1):83–89. doi: 10.1016/0009-8981(88)90177-5. [DOI] [PubMed] [Google Scholar]
  3. Al Mardini H., O'Brien C. J., Bartlett K., Williams R., Record C. O. Thermal desorption-gas chromatography of plasma isovaleraldehyde in hepatic encephalopathy in man. Clin Chim Acta. 1987 May 29;165(1):61–71. doi: 10.1016/0009-8981(87)90219-1. [DOI] [PubMed] [Google Scholar]
  4. Bansky G., Meier P. J., Riederer E., Walser H., Ziegler W. H., Schmid M. Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans. Gastroenterology. 1989 Sep;97(3):744–750. doi: 10.1016/0016-5085(89)90647-1. [DOI] [PubMed] [Google Scholar]
  5. Baraldi M., Zeneroli M. L., Ventura E., Penne A., Pinelli G., Ricci P., Santi M. Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: reversal by a benzodiazepine antagonist. Clin Sci (Lond) 1984 Aug;67(2):167–175. doi: 10.1042/cs0670167. [DOI] [PubMed] [Google Scholar]
  6. Basile A. S., Gammal S. H., Jones E. A., Skolnick P. GABAA receptor complex in an experimental model of hepatic encephalopathy: evidence for elevated levels of an endogenous benzodiazepine receptor ligand. J Neurochem. 1989 Oct;53(4):1057–1063. doi: 10.1111/j.1471-4159.1989.tb07395.x. [DOI] [PubMed] [Google Scholar]
  7. Basile A. S., Gammal S. H., Mullen K. D., Jones E. A., Skolnick P. Differential responsiveness of cerebellar Purkinje neurons to GABA and benzodiazepine receptor ligands in an animal model of hepatic encephalopathy. J Neurosci. 1988 Jul;8(7):2414–2421. doi: 10.1523/JNEUROSCI.08-07-02414.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bassett M. L., Mullen K. D., Scholz B., Fenstermacher J. D., Jones E. A. Increased brain uptake of gamma-aminobutyric acid in a rabbit model of hepatic encephalopathy. Gastroenterology. 1990 Mar;98(3):747–757. doi: 10.1016/0016-5085(90)90298-f. [DOI] [PubMed] [Google Scholar]
  9. Bassett M. L., Mullen K. D., Skolnick P., Jones E. A. Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure. Gastroenterology. 1987 Nov;93(5):1069–1077. doi: 10.1016/0016-5085(87)90571-3. [DOI] [PubMed] [Google Scholar]
  10. Bergeron M., Reader T. A., Layrargues G. P., Butterworth R. F. Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Neurochem Res. 1989 Sep;14(9):853–859. doi: 10.1007/BF00964814. [DOI] [PubMed] [Google Scholar]
  11. Bergeron M., Swain M. S., Reader T. A., Grondin L., Butterworth R. F. Effect of ammonia on brain serotonin metabolism in relation to function in the portacaval shunted rat. J Neurochem. 1990 Jul;55(1):222–229. doi: 10.1111/j.1471-4159.1990.tb08842.x. [DOI] [PubMed] [Google Scholar]
  12. Blom H. J., Chamuleau R. A., Rothuizen J., Deutz N. E., Tangerman A. Methanethiol metabolism and its role in the pathogenesis of hepatic encephalopathy in rats and dogs. Hepatology. 1990 Apr;11(4):682–689. doi: 10.1002/hep.1840110424. [DOI] [PubMed] [Google Scholar]
  13. Bosman D. K., Deutz N. E., De Graaf A. A., vd Hulst R. W., Van Eijk H. M., Bovée W. M., Maas M. A., Jörning G. G., Chamuleau R. A. Changes in brain metabolism during hyperammonemia and acute liver failure: results of a comparative 1H-NMR spectroscopy and biochemical investigation. Hepatology. 1990 Aug;12(2):281–290. doi: 10.1002/hep.1840120215. [DOI] [PubMed] [Google Scholar]
  14. Brown D. M-currents: an update. Trends Neurosci. 1988 Jul;11(7):294–299. doi: 10.1016/0166-2236(88)90089-6. [DOI] [PubMed] [Google Scholar]
  15. Butterworth R. F., Lavoie J., Giguère J. F., Layrargues G. P., Bergeron M. Cerebral GABA-ergic and glutamatergic function in hepatic encephalopathy. Neurochem Pathol. 1987 Feb-Apr;6(1-2):131–144. doi: 10.1007/BF02833603. [DOI] [PubMed] [Google Scholar]
  16. Butterworth R. F., Lavoie J., Giguère J. F., Pomier-Layrargues G. Affinities and densities of high-affinity [3H]muscimol (GABA-A) binding sites and of central benzodiazepine receptors are unchanged in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Hepatology. 1988 Sep-Oct;8(5):1084–1088. doi: 10.1002/hep.1840080517. [DOI] [PubMed] [Google Scholar]
  17. Cuilleret G., Pomier-Layrargues G., Pons F., Cadilhac J., Michel H. Changes in brain catecholamine levels in human cirrhotic hepatic encephalopathy. Gut. 1980 Jul;21(7):565–569. doi: 10.1136/gut.21.7.565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Gammal S. H., Basile A. S., Geller D., Skolnick P., Jones E. A. Reversal of the behavioral and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands. Hepatology. 1990 Mar;11(3):371–378. doi: 10.1002/hep.1840110307. [DOI] [PubMed] [Google Scholar]
  19. Grimm G., Ferenci P., Katzenschlager R., Madl C., Schneeweiss B., Laggner A. N., Lenz K., Gangl A. Improvement of hepatic encephalopathy treated with flumazenil. Lancet. 1988 Dec 17;2(8625):1392–1394. doi: 10.1016/s0140-6736(88)90587-9. [DOI] [PubMed] [Google Scholar]
  20. Hindfelt B., Plum F., Duffy T. E. Effect of acute ammonia intoxication on cerebral metabolism in rats with portacaval shunts. J Clin Invest. 1977 Mar;59(3):386–396. doi: 10.1172/JCI108651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hourani B. T., Hamlin E. M., Reynolds T. B. Cerebrospinal fluid glutamine as a measure of hepatic encephalopathy. Arch Intern Med. 1971 Jun;127(6):1033–1036. [PubMed] [Google Scholar]
  22. Knell A. J., Davidson A. R., Williams R., Kantamaneni B. D., Curzon G. Dopamine and serotonin metabolism in hepatic encephalopathy. Br Med J. 1974 Mar 23;1(5907):549–551. doi: 10.1136/bmj.1.5907.549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Knudsen G. M., Poulsen H. E., Paulson O. B. Blood-brain barrier permeability in galactosamine-induced hepatic encephalopathy. No evidence for increased GABA-transport. J Hepatol. 1988 Apr;6(2):187–192. doi: 10.1016/s0168-8278(88)80030-8. [DOI] [PubMed] [Google Scholar]
  24. Lavoie J., Giguère J. F., Layrargues G. P., Butterworth R. F. Amino acid changes in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. J Neurochem. 1987 Sep;49(3):692–697. doi: 10.1111/j.1471-4159.1987.tb00949.x. [DOI] [PubMed] [Google Scholar]
  25. Lo W. D., Ennis S. R., Goldstein G. W., McNeely D. L., Betz A. L. The effects of galactosamine-induced hepatic failure upon blood-brain barrier permeability. Hepatology. 1987 May-Jun;7(3):452–456. doi: 10.1002/hep.1840070307. [DOI] [PubMed] [Google Scholar]
  26. Maddison J. E., Dodd P. R., Morrison M., Johnston G. A., Farrell G. C. Plasma GABA, GABA-like activity and the brain GABA-benzodiazepine receptor complex in rats with chronic hepatic encephalopathy. Hepatology. 1987 Jul-Aug;7(4):621–628. doi: 10.1002/hep.1840070402. [DOI] [PubMed] [Google Scholar]
  27. Maddison J. E., Yau D., Stewart P., Farrell G. C. Cerebrospinal fluid gamma-aminobutyric acid levels in dogs with chronic portosystemic encephalopathy. Clin Sci (Lond) 1986 Dec;71(6):749–753. doi: 10.1042/cs0710749. [DOI] [PubMed] [Google Scholar]
  28. Mans A. M., Saunders S. J., Kirsch R. E., Biebuyck J. F. Correlation of plasma and brain amino acid and putative neurotransmitter alterations during acute hepatic coma in the rat. J Neurochem. 1979 Feb;32(2):285–292. doi: 10.1111/j.1471-4159.1979.tb00350.x. [DOI] [PubMed] [Google Scholar]
  29. McDERMOTT W. V., Jr Metabolism and toxicity of ammonia. N Engl J Med. 1957 Nov 28;257(22):1076–1081. doi: 10.1056/NEJM195711282572205. [DOI] [PubMed] [Google Scholar]
  30. Moroni F., Riggio O., Carlà V., Festuccia V., Ghinelli F., Marino I. R., Merli M., Natali L., Pedretti G., Fiaccadori F. Hepatic encephalopathy: lack of changes of gamma-aminobutyric acid content in plasma and cerebrospinal fluid. Hepatology. 1987 Sep-Oct;7(5):816–820. doi: 10.1002/hep.1840070504. [DOI] [PubMed] [Google Scholar]
  31. Mullen K. D., Martin J. V., Mendelson W. B., Bassett M. L., Jones E. A. Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy? Lancet. 1988 Feb 27;1(8583):457–459. doi: 10.1016/s0140-6736(88)91245-7. [DOI] [PubMed] [Google Scholar]
  32. Mullen K. D., Szauter K. M., Kaminsky-Russ K. "Endogenous" benzodiazepine activity in body fluids of patients with hepatic encephalopathy. Lancet. 1990 Jul 14;336(8707):81–83. doi: 10.1016/0140-6736(90)91594-z. [DOI] [PubMed] [Google Scholar]
  33. Parkes J. D., Sharpstone P., Williams R. Levodopa in hepatic coma. Lancet. 1970 Dec 26;2(7687):1341–1343. doi: 10.1016/s0140-6736(70)92362-7. [DOI] [PubMed] [Google Scholar]
  34. Perry T. L., Hansen S., Gandham S. S. Postmortem changes of amino compounds in human and rat brain. J Neurochem. 1981 Feb;36(2):406–410. doi: 10.1111/j.1471-4159.1981.tb01608.x. [DOI] [PubMed] [Google Scholar]
  35. Raabe W. Synaptic transmission in ammonia intoxication. Neurochem Pathol. 1987 Feb-Apr;6(1-2):145–166. doi: 10.1007/BF02833604. [DOI] [PubMed] [Google Scholar]
  36. Record C. O., Buxton B., Chase R. A., Curzon G., Murray-Lyon I. M., Williams R. Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy. Eur J Clin Invest. 1976 Sep 10;6(5):387–394. doi: 10.1111/j.1365-2362.1976.tb00533.x. [DOI] [PubMed] [Google Scholar]
  37. Roy S., Pomier-Layrargues G., Butterworth R. F., Huet P. M. Hepatic encephalopathy in cirrhotic and portacaval shunted dogs: lack of changes in brain GABA uptake, brain GABA levels, brain glutamic acid decarboxylase activity and brain postsynaptic GABA receptors. Hepatology. 1988 Jul-Aug;8(4):845–849. doi: 10.1002/hep.1840080424. [DOI] [PubMed] [Google Scholar]
  38. Rössle M., Deckert J., Jones E. A. Autoradiographic analysis of GABA-benzodiazepine receptors in an animal model of acute hepatic encephalopathy. Hepatology. 1989 Aug;10(2):143–147. doi: 10.1002/hep.1840100204. [DOI] [PubMed] [Google Scholar]
  39. STAHL J. Studies of the blood ammonia in liver disease. Its diagnostic, prognostic, and therapeutic significance. Ann Intern Med. 1963 Jan;58:1–24. doi: 10.7326/0003-4819-58-1-1. [DOI] [PubMed] [Google Scholar]
  40. Schafer D. F., Fowler J. M., Munson P. J., Thakur A. K., Waggoner J. G., Jones E. A. Gamma-aminobutyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure. J Lab Clin Med. 1983 Dec;102(6):870–880. [PubMed] [Google Scholar]
  41. Schafer D. F., Jones E. A. Hepatic encephalopathy and the gamma-aminobutyric-acid neurotransmitter system. Lancet. 1982 Jan 2;1(8262):18–20. doi: 10.1016/s0140-6736(82)92559-4. [DOI] [PubMed] [Google Scholar]
  42. Tossman U., Delin A., Eriksson L. S., Ungerstedt U. Brain cortical amino acids measured by intracerebral dialysis in portacaval shunted rats. Neurochem Res. 1987 Mar;12(3):265–269. doi: 10.1007/BF00972136. [DOI] [PubMed] [Google Scholar]
  43. Tossman U., Eriksson S., Delin A., Hagenfeldt L., Law D., Ungerstedt U. Brain amino acids measured by intracerebral dialysis in portacaval shunted rats. J Neurochem. 1983 Oct;41(4):1046–1051. doi: 10.1111/j.1471-4159.1983.tb09049.x. [DOI] [PubMed] [Google Scholar]
  44. Yurdaydin C., Hörtnagl H., Steindl P., Zimmermann C., Pifl C., Singer E. A., Roth E., Ferenci P. Increased serotoninergic and noradrenergic activity in hepatic encephalopathy in rats with thioacetamide-induced acute liver failure. Hepatology. 1990 Oct;12(4 Pt 1):695–700. doi: 10.1002/hep.1840120413. [DOI] [PubMed] [Google Scholar]
  45. Zieve L., Ferenci P., Rzepczynski D., Ebner J., Zimmermann C. A benzodiazepine antagonist does not alter the course of hepatic encephalopathy or neural gamma-aminobutyric acid (GABA) binding. Metab Brain Dis. 1987 Sep;2(3):201–205. doi: 10.1007/BF00999611. [DOI] [PubMed] [Google Scholar]
  46. Zimmermann C., Ferenci P., Pifl C., Yurdaydin C., Ebner J., Lassmann H., Roth E., Hörtnagl H. Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission. Hepatology. 1989 Apr;9(4):594–601. doi: 10.1002/hep.1840090414. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES